Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PsA-TT versus meningococcal ACWY polysaccharide vaccine in healthy children
ISRCTN46335400Phase 3Completed
- Sponsor
- Serum Institute of India
- Start
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, single-blind trial of meningococcal A conjugate vaccine and quadrivalent meningococcal polysaccharide vaccine in meningococcal disease and bacterial meningitis (2 arms), sponsored by Serum Institute of India. Primary endpoint: Seroconversion for anti-meningococcal polysaccharide A antibodies at 28 days. Started Aug 2007; status: completed.
02
Drugs
meningococcal A conjugate vaccinequadrivalent meningococcal polysaccharide vaccine
03
Conditions
meningococcal diseasebacterial meningitis
Beyond the preview
Go deeper on ISRCTN46335400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN46335400.